Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

Benralizumab, the first new treatment for asthma and chronic obstructive pulmonary disease (COPD), is being called a ...

your symptoms happen when you come into contact with an asthma trigger, like pollen or animals or when you have a cold or ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" ...

Asthma and chronic obstructive pulmonary disease (COPD) are significant health challenges, with asthma affecting around ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

A groundbreaking new treatment for asthma and chronic obstructive pulmonary disease (COPD) is being hailed by doctors as a ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

The main advances in asthma management are related to different strategies for improved disease control ... also many nonpharmacologic strategies (pulmonary rehabilitation [PR], mechanical ...